Kailera soars over 60% in Nasdaq debut as weight-loss drug race heats up
Weight-loss drug developer Kailera Therapeutics' shares surged 62.5% in their Nasdaq debut on Friday after closing a $625 million U.S. initial public offering, as
April 17, 2026
Trump administration sues New Jersey over law enforcement mask ban
UK firms' worries about economy rise by most since 2020, Lloyds survey shows
Bank of England set to hold rates as Iran war clouds outlook
Amazon tops cloud expectations on strong AI demand, shares rise
Trial set for Overland Park man accused of stabbing captain on Hawaii snorkel tour
Kansas City man accused of high-speed chase in stolen SUV, fleeing into floodwater
George Pickens signs $27.3 million franchise tag with Cowboys, opening door for offseason work